Buy Unichem Laboratories: Joshi

ALSO READ See previous views by Sharmila Joshi See what other Experts & Brokerages are saying about Unichem Labs See messages about Unichem Labs Unichem Labs BSE | NSE 21/02/12 Are Mutual Funds betting on Unichem Labs?

Buy Unichem Laboratories , says Sharmila Joshi , Co-Head PCG Sales, Emkay Global Financial Services.

Joshi told CNBC-TV18, "Unichem Laboratories is a good stock to be looking at in the pharma space. Their domestic business is very strong and we are now looking at companies where domestic business is giving you better signals largely because we have seen that whether its Ranbaxy or anybody who has a US exposure does have some kind of issues there but just looking at the way Unichem has been growing on the domestic side we do have a fundamental buy call on the company."

Unichem Labs has touched an intraday high of Rs 416.00 and an intraday low of Rs 380.75 with volumes of 135,891 shares. Yesterday the share closed up 1.64% or Rs 6.15 at Rs 380.15.

Market capitalisation stands at Rs 1,426.22 crore.

The company's trailing 12-month (TTM) EPS was at Rs 35.56 per share. The stock's price-to-earnings (P/E) ratio was 11.12. The latest book value of the company is Rs 144.19 per share. At current value, the price-to-book value of the company was 2.74. The dividend yield of the company was 2.02%.